Bank of Ireland's CEO Sells Shares, Buys Pay Plan—Smart Money Watches Misalignment

The new pay plan for Bank of Ireland's top brass is a classic case of promising skin in the game while keeping the actual risk low. The centerpiece is a 2023 equity award that could boost the CEO's total compensation by as much as 50% of his salary, starting in 2024. But the catch is in the fine print: the first year's award is capped at 25% of salary. This structure, which only fully unlocks the 50% potential from 2025 onward, is a slow drip of incentive rather than a performance trigger.

The CEO's base salary itself is a starting point of €950,000. When layered with the new Profit Share Scheme, which caps individual awards at 10% of salary or €20,000, the total package looks substantial. Yet the scheme's design raises a red flag. The profit share is based on both company and individual performance, but the lack of clear, ambitious hurdles for the equity awards means the payout is more a guaranteed bonus than a true alignment with shareholder returns. In other words, the smart money would want to see the equity vest only if the bank hits specific, tough targets for return on equity or earnings growth. This plan doesn't.

The timing is particularly telling. This pay boost comes as the bank's top executives have been quietly reducing their exposure to the stock. While the company touts its "progressive" approach to retention, the real signal is in the filings. When the people in charge are selling while the pay committee is handing out new equity, it's a classic setup for a misalignment. The new plan may help keep talent, but it does little to ensure that talent is working to make the stock go up. For shareholders, that's the missing piece.

Insider Moves: What's the Whale Wallet Doing?

The real signal isn't in the pay plan-it's in the trades. While the board was busy crafting a new compensation package, the Group CEO was quietly taking money off the table. Last year, Myles O'Grady sold shares worth €56,000 at about €11.01 per share. That sale happened at a price significantly below the stock's current level of roughly €13.65. In the language of smart money, that's a clear signal: the person at the top of the bank saw a reasonable exit point when the shares were trading lower, and he took it.

This isn't an isolated move. The evidence shows a pattern of selling. Over the last year, a number of Bank of Ireland insiders sold their shares, with O'Grady's €56,000 transaction being the largest. The lack of any insider buying during that period is telling. When the people with the best view of the bank's health are consistently selling, it raises a red flag, regardless of their stated reasons. It suggests they may be diversifying their personal portfolios or simply cashing in on a recent run-up, but it does nothing to align their fortunes with a future rally.

The data for the most recent quarter is a bit of a blank slate. There have been no insider transactions in the past three months, which means we can't see if the selling pressure has eased. But the longer-term trend is clear. The smart money, in the form of the CEO and other insiders, has been net sellers. For shareholders, that's a weak but consistent sign. It means the skin in the game is being reduced just as the company is promising more of it through pay plans. When the whales are bailing, it's a reminder to watch the water.

The Growth Trap: A Target Revisited

The CEO's new loan growth target is a bold promise, but history and recent risk signals suggest it's a classic growth trap. Myles O'Grady is aiming for a 4% annual increase in the loan book out to 2028, targeting a total of €90 billion. The problem is, he's trying to walk a path that two predecessors quietly abandoned. Their efforts to rebuild to that level were hampered by a domestic economy that was paying down debt faster than it was taking on new loans, a slow housing market, and external shocks like Brexit and the pandemic.

O'Grady has a different setup. He points to a 33% growth in the loan book over the last three years and a domestic economy he sees growing at an average of 3% annually. But the smart money would note the recent risk buildup. Just last month, the bank raised its full-year impairment charge, setting aside more money to cover potential losses in its U.S. acquisition finance business. This preemptive move signals higher risk in that portfolio, which is a material part of the bank's total loan book.

The bottom line is a tension between ambition and prudence. The CEO is confident, but the bank's own actions show it's preparing for trouble. When a leader sets a target that failed his predecessors, while simultaneously raising provisions for losses in a key lending segment, it's a setup for disappointment. The smart money would watch the loan growth numbers closely, but they'd also watch the risk provisions. If the U.S. business continues to require higher charges, the path to a €90 billion loan book becomes steeper and riskier. For now, the target looks more like a stretch goal than a guaranteed outcome.

Catalysts and Risks: What to Watch

The setup here is clear: a CEO who sold shares last year at a discount to the current price is now leading a bank with a new pay plan that offers big upside but weak performance hurdles. The smart money will watch two key areas to see if this misalignment holds or corrects.

First, watch for any significant insider buying in the coming quarters. The recent pattern is a net sell, with the CEO's €56,000 sale being the largest. While no insider transactions have occurred in the past three months, the longer-term trend is a red flag. If the CEO and other insiders start buying back in, it would contradict the recent exit and signal renewed confidence. The absence of such buying, however, would reinforce the view that the skin in the game is being reduced just as the company promises more of it.

Second, monitor the bank's quarterly loan growth figures against the 4% target. This is the core of O'Grady's strategy, but it's a path his predecessors failed to walk. The bank's recent move to raise its full-year impairment charge shows risk is building in key lending segments. If loan growth stalls or the bank is forced to raise more provisions, it will strain the path to a €90 billion book. The smart money will look for traction in the numbers, but they'll also watch the risk provisions. A clean growth story is needed to justify the CEO's confidence and the pay plan's potential.

The key risk is that high executive pay without strong performance hurdles encourages risk-taking that benefits insiders but not shareholders. The new plan offers a 50% salary boost, but only if the bank hits targets from 2025 onward. That's a long runway. In the meantime, the CEO has already taken money off the table. For the thesis to hold-that this is a misaligned setup-the coming quarters must show either a reversal in insider selling or a stumble in the loan growth strategy. Until then, the smart money has a reason to stay on the sidelines.